DETERMINATION OF CYP2D6 PHENOTYPING FOR METOPROLOL USING THE CYP2D6 GENOTYPE-DERIVED ACTIVITY SCORE: RESULTS FROM A PROSPECTIVE, CLINICAL TRIAL.

被引：0
|
作者：
Thomas, C. D. [1 ]
Mosley, S. A. [1 ]
El Rouby, N. [1 ]
Kim, S. [2 ]
Lingineni, K. [2 ]
Langaee, T. [1 ]
Gong, Y. [1 ]
Johnson, J. A. [1 ]
Schmidt, S. O. [1 ]
Schmidt, S. [2 ]
Frye, R. F. [1 ]
Cavallari, L. H. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Florida, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LB-028
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores
    Thomas, Cameron D.
    Mosley, Scott A.
    Kim, Sarah
    Lingineni, Karthik
    El Rouby, Nihal
    Langaee, Taimour Y.
    Gong, Yan
    Wang, Danxin
    Schmidt, Siegfried O.
    Binkley, Philip F.
    Estores, David S.
    Feng, Kairui
    Kim, Hyewon
    Kinjo, Minori
    Li, Zhichuan
    Fang, Lanyan
    Chapman, Arlene B.
    Cooper-DeHoff, Rhonda M.
    Gums, John G.
    Hamadeh, Issam S.
    Zhao, Liang
    Schmidt, Stephan
    Frye, Reginald F.
    Johnson, Julie A.
    Cavallari, Larisa H.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (12): : 678 - 685
  • [2] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [3] Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study
    Rau, T.
    Wuttke, H.
    Michels, L. M.
    Werner, U.
    Bergmann, K.
    Kreft, M.
    Fromm, M. F.
    Eschenhagen, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) : 269 - 272
  • [4] CYP2D6 phenotyping with dextromethorphan
    Wojtczak, Anna
    Rychlik-Sych, Mariola
    Krochmalska-Ulacha, Eliza
    Skretkowicz, Jadwiga
    PHARMACOLOGICAL REPORTS, 2007, 59 (06) : 734 - 738
  • [5] The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva
    Jin, Ye
    Zhang, Shuquan
    Hu, Pei
    Zheng, Xin
    Guan, Xiaoduo
    Chen, Rui
    Zhang, Shuyang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] The use of Yohimbine for phenotyping of CYP2D6 activity
    Vay, M.
    Rose, P.
    Meyer, M.
    Mikus, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S24 - S24
  • [7] OUTPATIENT CYP2D6 GENOTYPE-SUPPORTED OPIOID THERAPY: A PROSPECTIVE TRIAL.
    Smith, D. M.
    Weitzel, K. W.
    Elsey, A. R.
    Wake, D. T.
    Gong, Y.
    Duong, B. Q.
    Newsom, K.
    Smith, S. M.
    Starostik, P.
    Clare-Salzler, M. J.
    Schmidt, S. O.
    Johnson, J. A.
    Fillingim, R.
    Cavallari, L. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S8 - S8
  • [8] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [9] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [10] CYP2D6 GENOTYPE DETERMINATION IN THE DANISH POPULATION
    BROSEN, K
    NIELSEN, PN
    BRUSGAARD, K
    GRAM, LF
    SKJODT, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (03) : 221 - 225
12345